DEVELOPMENT OF GANCICLOVIR RESISTANCE DURING TREATMENT OF PRIMARY CYTOMEGALOVIRUS INFECTION AFTER LIVER TRANSPLANTATION1
- 1 February 1997
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 63 (3), 476-478
- https://doi.org/10.1097/00007890-199702150-00026
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- CYTOMEGALOVIRUS PROPHYLAXIS IN SOLID ORGAN TRANSPLANT RECIPIENTSTransplantation, 1996
- Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipientsThe Lancet, 1995
- Frequency of UL97 Phosphotransferase Mutations Related to Ganciclovir Resistance in Clinical Cytomegalovirus IsolatesThe Journal of Infectious Diseases, 1995
- Failure of High-Dose Oral Acyclovir to Suppress CMV Viruria or Induce Ganciclovir-Resistant CMV in HIV Antibody Positive PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1995
- Analysis Of The Ul97 Phosphotransferase Coding Sequence In Clinical Cytomegalovirus Isolates And Identification Of Mutations Conferring Ganciclovir ResistanceThe Journal of Infectious Diseases, 1995
- Ganciclovir Susceptibilities of Cytomegalovirus (CMV) Isolates from Solid Organ Transplant Recipients with CMV Viremia after Antiviral ProphylaxisThe Journal of Infectious Diseases, 1993
- THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus InfectionThe Journal of Infectious Diseases, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989